Theravance Biopharma Inc (TBPH.O)

+ 收藏

资产负债表(Theravance Biopharma Inc)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年年报2025年三季报2025年中报2025年一季报2024年年报2024年三季报2024年中报2024年一季报
截止日期 2025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 12311231123112311231123112311231
原始币种 美元美元美元美元美元美元美元美元
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后上市后
流动资产:
 现金及现金等价物(元) 会员可见会员可见会员可见会员可见37,797,000.0023,378,000.0046,345,000.0053,835,000.00
 应收账款及票据(元) 会员可见---50,000,000.00---
 应收关联方款项(元) 会员可见会员可见会员可见会员可见18,440,000.0016,845,000.0014,299,000.0014,664,000.00
 预付款项及其他应收款流动(元) 会员可见会员可见会员可见会员可见4,277,000.008,274,000.008,930,000.009,655,000.00
 短期投资(元) 会员可见会员可见会员可见会员可见50,553,000.0067,983,000.0049,733,000.0046,140,000.00
 流动资产合计(元) 会员可见会员可见会员可见会员可见161,067,000.00116,480,000.00119,307,000.00124,294,000.00
非流动资产:
 物业、厂房及设备(元) 会员可见会员可见会员可见会员可见7,418,000.007,788,000.008,142,000.008,717,000.00
 受限制存款及现金非流动(元) 会员可见会员可见会员可见会员可见836,000.00836,000.00836,000.00836,000.00
 长期投资(元) 会员可见会员可见------
 非流动资产其他项目(元) 会员可见会员可见会员可见会员可见184,840,000.00231,001,000.00233,744,000.00237,460,000.00
 非流动资产合计(元) 会员可见会员可见会员可见会员可见193,094,000.00239,625,000.00242,722,000.00247,013,000.00
总资产(元) 会员可见会员可见会员可见会员可见354,161,000.00356,105,000.00362,029,000.00371,307,000.00
流动负债:
 融资租赁负债流动(元) 会员可见会员可见会员可见会员可见10,712,000.004,196,000.004,219,000.004,063,000.00
 应付账款及票据(元) 会员可见会员可见会员可见会员可见2,242,000.001,454,000.001,674,000.001,686,000.00
 应付税项流动(元) 会员可见会员可见会员可见会员可见5,853,000.00---
 应付薪酬和福利(元) 会员可见会员可见会员可见会员可见7,019,000.007,842,000.005,774,000.004,475,000.00
 其他应付款及应计费用(元) 会员可见会员可见会员可见会员可见6,259,000.009,943,000.0011,279,000.0011,438,000.00
 流动负债合计(元) 会员可见会员可见会员可见会员可见32,085,000.0023,435,000.0022,946,000.0021,662,000.00
非流动负债:
 长期债务(元) 会员可见会员可见会员可见会员可见1,890,000.004,977,000.004,885,000.005,445,000.00
 融资租赁负债非流动(元) 会员可见会员可见会员可见会员可见39,108,000.0040,785,000.0042,441,000.0043,840,000.00
 非流动负债其他项目(元) 会员可见会员可见会员可见会员可见105,533,000.00101,254,000.0098,068,000.0095,492,000.00
 非流动负债合计(元) 会员可见会员可见会员可见会员可见146,531,000.00147,016,000.00145,394,000.00144,777,000.00
总负债(元) 会员可见会员可见会员可见会员可见178,616,000.00170,451,000.00168,340,000.00166,439,000.00
股东权益:
 普通股(元) 会员可见会员可见会员可见会员可见----
 股本溢价(元) 会员可见会员可见会员可见会员可见1,141,060,000.001,135,599,000.001,131,008,000.001,125,677,000.00
 留存收益(元) 会员可见会员可见会员可见会员可见-965,522,000.00-949,995,000.00-937,297,000.00-920,768,000.00
 累计其他全面收益(元) 会员可见会员可见会员可见-7,000.0050,000.00-22,000.00-41,000.00
 归属于母公司股东权益(元) 会员可见会员可见会员可见会员可见175,545,000.00185,654,000.00193,689,000.00204,868,000.00
 股东权益合计(元) 会员可见会员可见会员可见会员可见175,545,000.00185,654,000.00193,689,000.00204,868,000.00
负债及股东权益合计(元) 会员可见会员可见会员可见会员可见354,161,000.00356,105,000.00362,029,000.00371,307,000.00
公告日期 2026-03-232025-11-122025-08-132025-05-122025-03-072024-11-142024-08-082024-05-15
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院